Advion

NEW YORK (GenomeWeb News) – Advion said on Monday it has signed an exclusive original equipment manufacturing and distribution partnership deal with Swiss firm CAMAG for Advion's TLC/MS interface product.

NEW YORK (GenomeWeb News) – Advion today said that it has inked a distribution agreement with Konik Group covering Spain, Portugal, and South America, excluding Brazil.

NEW YORK (GenomeWeb News) – Advion today said that its expression compact mass spectrometer has been integrated with liquid chromatography systems from Agilent Technologies.

NEW YORK (GenomeWeb News) – Advion today said that it has signed an agreement with Valtex International for distribution of the firm's expression compact mass spectrometer in Russia.

While LC-MS/MS workflows using triple quadrupoles and, more recently, Q-TOF and Q-Exactive instruments, have typically dominated discussion of mass spec-based protein quantitation, MALDI mass spec has recently emerged as a potential alternative for such applications.

NEW YORK (GenomeWeb News) – Advion said late on Thursday it has named Government Scientific Source as a US government distributor for the company's new expression CMS compact mass spec.

Alex Bateman is joining the European Bioinformatics Institute as head of protein sequence resources, replacing Rolf Apweiler.

NEW YORK (GenomeWeb News) – Advion today announced the appointment of Scientifix as the exclusive distributor for its expression compact mass spectrometer in Australia.

NEW YORK (GenomeWeb News) – Life sciences and consumables firm Advion continued on its expansion into the international markets today announcing a deal with Yair Technologies for the distribution of Advion's expression compact mass spectrometer in Israel.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Advion today said it has appointed Inkarp Instruments to be its distributor in India.

Pages

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.